These data demonstrate that PDX-1 knockdown using systemic bi-shRNAmousePDX-1 lipoplexes effectively prevents hyperinsulinemic, hypoglycemic death in an insulinoma SCID mouse model; therefore, the treatments control excessive hormonal secretion associated with this form of islet neoplasia. Here, PDX1 is linked to pancreatic insulinoma.